Integrated Continuum Services to Access the French Market.
Cevidra is your GMP/GDP pharmaceutical structure offering the organisation, resources and expertise to access the French market, covering Early Access Programs, Compassionate Access & Licensed products.
Early Access Programs
Access for patients in therapeutic impasse, before or after MA, with free pricing.
Market Access & Price & Reimbursement
Full regulatory pathway: HAS evaluation, CEPS negotiations, commercial launch.
Supply Chain & Logistics
GDP-compliant storage, cold chain, 800+ hospitals delivered, 99% success rate.
Who We Are
An independent, family-owned French pharmaceutical company supporting global pharma to access the French market since 2007.
CPCO: Contract Pharmaceutical Commercial Organization
Cevidra is your GMP/GDP pharmaceutical structure offering the organisation, resources and expertise to access the French market. We act as a French local subsidiary for small & mid-size companies to support the launch, storage, distribution, sales and market access of their medicinal products.
Our strength lies in the agility and reactivity of our dedicated project manager and the provision of our well-established professional network to help you on the road to success.
One-stop Solution
Single point of contact for all services
GMP/GDP Certified
Regularly inspected by the ANSM
20 Experts
Dedicated pharma team in Grasse, France
French Network
Well-established professional connections
Meet the Team
A multidisciplinary team of pharma professionals dedicated to your success in France.
Stéphane Destaing
Founder & Chief Executive OfficerBA in Business Management, MBA at HEC Paris and a Master in International Taxation at HEC. President of Cevidra with 20 years of experience, supporting European and non-European pharmaceutical companies in marketing their products in France through full delegation of local responsibilities.
Julie Priola
Chief Pharmaceutical Officer (QP) & Quality Assurance DirectorPharmacist and Chemical Engineer with more than 15 years of experience. Oversees the GMP and GDP Quality Management System and serves as Cevidra's Data Protection Officer.
Sonia Menard
Quality Pharmacist
Caroline Morais
Administrative & Logistic Assistant
Alain Distisheim
ConsultantWhat Do You Need?
Pharmaceutical tailored-made services to access the French market. Choose the pathway that fits your product lifecycle stage.
Market Access & Registration
From regulatory support to pricing & reimbursement, Cevidra manages all the complex steps between your MA and full commercial launch in France.
- Registration strategy & MA application preparation
- National packaging approval & compliance
- HAS & CEPS application management
- Direct Price & Reimbursement negotiations on behalf of MAH
- Product launch & hospital referencing
Supply Chain & Distribution
From storage to distribution of your product to hospitals. Cevidra has its own logistics platform for product storage, stock monitoring, delivery and cash collection.
- GDP-compliant warehousing & cold chain
- Order management & invoicing
- Public tender management & competitive bidding
- Hospital & wholesaler platform referencing
- Secondary packaging & batch release
Pre-MA Early Access (AP1)
For products without Marketing Authorization yet. Early access allows patients who have reached a therapeutic impasse to benefit from certain medicinal products before the commercial launch.
- HAS authorization & dossier management
- Product compliance & approved labelling
- Data collection from doctors & patients
- Medical information & MedInfo handling
- Pharmacovigilance & local PV person
Compassionate Use & Named Patient
For products with MA pending reimbursement or for individual patient needs. The price is freely defined by the company and fully reimbursed to hospitals.
- Compassionate access program management
- Named patient importation
- Free pricing & full hospital reimbursement
- Pharmacovigilance & safety reporting
- Smooth transition to commercial phase
Let's Discuss
Your Project
Cevidra is a GMP/GDP compliant company providing tailored-made services & a one-stop solution to bring medicines to the French market. Our strength lies in the agility and reactivity of our dedicated project manager.
Book a Meeting
Fill in the form and we'll arrange a call at your convenience.
How We Help Pharma Companies
Real-world examples of how Cevidra helps pharmaceutical companies successfully enter and grow in the French market.
Orphan Drug Launch via Early Access Program
A US biotech needed to bring an orphan drug to French patients before MA. Cevidra managed the entire Early Access process from HAS authorization to hospital distribution and data collection.
"Cevidra's expertise in early access was instrumental in getting our therapy to patients months ahead of schedule."
Full Market Access for Hospital-Only Product
A mid-size pharma company needed an exploitant in France for their specialty hospital product. Cevidra handled registration, Price & Reimbursement negotiations, tender management and logistics.
"Having a single partner manage everything from AMM to delivery made our France launch seamless."
Exploitant Services for Complex Biologics
A global company required a French exploitant for blood-derived products. Cevidra provided regulatory compliance, pharmacovigilance, cold-chain logistics and post-market surveillance.
"Their deep knowledge of French regulations for sensitive products gave us complete confidence."
Ready to Access the French Market?
Whether you need Early Access, Market Authorization, or full distribution services, Cevidra acts as your French local subsidiary. No need to set up your own entity.
Frequently Asked Questions
Everything you need to know about launching your product in France.
